Filing Details

Accession Number:
0001121781-15-000199
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-17 17:45:54
Reporting Period:
2015-05-29
Filing Date:
2015-07-17
Accepted Time:
2015-07-17 17:45:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
924515 Guided Therapeutics Inc GTHP Electromedical & Electrotherapeutic Apparatus (3845) 582029543
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1388125 W Ronald Hart 4821 Crestwood Drive
Little Rock AR 72207
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-29 5,682 $0.00 696,748 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options Acquisiton 2015-05-29 600,000 $0.00 600,000 $0.10
Common Stock Tranche A Warrants Disposition 2015-06-19 18,382 $0.00 18,382 $1.08
Common Stock Tranche B Warrants Disposition 2015-06-19 189,889 $0.00 189,889 $0.10
Common Stock Tranche A Warrants Acquisiton 2015-06-19 18,382 $0.00 18,382 $0.10
Common Stock Tranche B Warrants Acquisiton 2015-06-19 189,889 $0.00 189,889 $0.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,255,000 2015-05-29 2025-05-28 No 4 A Direct
0 2013-05-22 2018-05-22 No 4 S Direct
0 2013-05-22 2018-05-22 No 4 S Direct
18,382 2013-05-22 2018-05-22 No 4 P Direct
189,889 2013-05-22 2018-05-22 No 4 P Direct
Footnotes
  1. On June 30, 2015, the reporting person disposed of warrants to purchase common stock in exchange for new warrants to purchase common stock and shares of common stock in an exchange with the issuer.
  2. These shares were granted as dividend on the issuer's Series B preferred stock.
  3. These options to purchase common stock were granted under the Guided Therapeutics, Inc. 1995 Stock Plan as amended; as 2015 director's fees, in lieu of cash. The options are 100% vested.